For research purposes only. Not for human or veterinary use.
Survodutide is a synthetic peptide dual agonist acting on both the glucagon receptor and the GLP-1 receptor. Research has examined its combined incretin and glucagon-pathway activity, studied in metabolic research models for its effects on energy expenditure, hepatic fat content, and glycemic regulation.
For research purposes only. Not for human or veterinary use.